These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28289586)

  • 1. Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus.
    Šeruga M; Makuc J; Završnik M; Cilenšek I; Ekart R; Petrovič D
    Balkan J Med Genet; 2016 Dec; 19(2):29-34. PubMed ID: 28289586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy.
    Fawwaz S; Balbaa M; Fakhoury H; Borjac J; Fakhoury R
    Saudi J Kidney Dis Transpl; 2017; 28(2):325-329. PubMed ID: 28352015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.
    Younas H; Ijaz T; Choudhry N
    PLoS One; 2022; 17(2):e0264038. PubMed ID: 35176079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.
    Lu M; Zhang J; Li M; Ge X; Dai X; Zhao J; Fu M; Wang T; Fang X; Li C; Zhang R; Zhao W; Zheng T; Wang F; Yu M; Lei T; Wang N; Bao Y; Liu L; Liu Y; Jia W
    Mol Cell Biochem; 2016 Nov; 422(1-2):181-188. PubMed ID: 27633502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.
    Al-Harbi EM; Farid EM; Gumaa KA; Masuadi EM; Singh J
    Mol Cell Biochem; 2011 Apr; 350(1-2):119-25. PubMed ID: 21207118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Type 2 Diabetic Nephropathy in Asian Populations: An Updated Meta-analysis.
    Ahmad N; Jamal R; Shah SA; Gafor AHA; Murad NAA
    Curr Diabetes Rev; 2019; 15(4):263-276. PubMed ID: 29984662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between clinical characteristics and angiotensin-converting enzyme gene insertion/deletion polymorphism in Moroccan population with Type-2 diabetic nephropathy.
    Mansouri M; Zniber A; Boualla L; El Badaoui G; Benkacem M; Rifai K; Chraibi A; Benamar L; Sefiani A; Bayahia R
    Saudi J Kidney Dis Transpl; 2017; 28(2):261-267. PubMed ID: 28352005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
    J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch Region.
    Parchwani DN; Palandurkar KM; Hema Chandan Kumar D; Patel DJ
    Indian J Clin Biochem; 2015 Jan; 30(1):43-54. PubMed ID: 25646040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated ACE Levels Indicate Diabetic Nephropathy Progression or Companied Retina Impaired.
    Huang K; Liang Y; Wang K; Ma Y; Wu J; Luo H; Yi B
    Front Clin Diabetes Healthc; 2022; 3():831128. PubMed ID: 36992775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 (IL4) -590C/T (rs2243250) gene polymorphism is not associated with diabetic nephropathy (DN) in Caucasians with type 2 diabetes mellitus (T2DM).
    Završnik M; Letonja J; Makuc J; Šeruga M; Cilenšek I; Petrovič D
    Bosn J Basic Med Sci; 2018 Nov; 18(4):347-351. PubMed ID: 29514038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus.
    Ilić V; Ilić M; Soldatović I; Popović S; Magić Z
    Vojnosanit Pregl; 2014 Jul; 71(7):627-33. PubMed ID: 25109108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes.
    Fathi M; Nikzamir AR; Esteghamati A; Nakhjavani M; Yekaninejad MS
    Iran Red Crescent Med J; 2015 Feb; 17(2):e19469. PubMed ID: 25834741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of angiotensin-converting enzyme insertion/deletion polymorphism with type 1 diabetic nephropathy: a meta-analysis.
    Xu HY; Liu MM; Wang X; He XY
    Ren Fail; 2016 Oct; 38(9):1320-1327. PubMed ID: 27498976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
    Hunsicker LG
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S12-7. PubMed ID: 15369420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.